Aref Chehal

511 total citations
21 papers, 328 citations indexed

About

Aref Chehal is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Aref Chehal has authored 21 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Genetics and 6 papers in Hematology. Recurrent topics in Aref Chehal's work include Chronic Lymphocytic Leukemia Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Aref Chehal is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Aref Chehal collaborates with scholars based in Lebanon and France. Aref Chehal's co-authors include Alì Taher, Ali Shamseddine, Elie Aoun, Yasser Abou Mourad, Ziad Salem, Ziyad Mahfoud, Mariana Salamoun, Ghada El‐Hajj Fuleihan, Suzanne Koussa and Salam Koussa and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Spine and Clinical Pharmacokinetics.

In The Last Decade

Aref Chehal

19 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aref Chehal Lebanon	10	136	133	118	68	48	21	328
Sabine Bréchignac France	12	274 2.0×	367 2.8×	72 0.6×	27 0.4×	34 0.7×	32	526
R. Fanin Italy	8	139 1.0×	384 2.9×	184 1.6×	11 0.2×	54 1.1×	12	519
Laurent Pascal France	9	195 1.4×	272 2.0×	136 1.2×	16 0.2×	41 0.9×	25	438
Maximilian Merz Germany	13	59 0.4×	369 2.8×	216 1.8×	26 0.4×	13 0.3×	38	451
Michela Ceccolini Italy	11	75 0.6×	625 4.7×	441 3.7×	39 0.6×	30 0.6×	21	734
Miriam Quitt Israel	11	70 0.5×	103 0.8×	67 0.6×	6 0.1×	39 0.8×	31	299
Christiane Heiß Germany	11	158 1.2×	614 4.6×	292 2.5×	87 1.3×	9 0.2×	17	784
Caroline An United States	8	107 0.8×	96 0.7×	112 0.9×	5 0.1×	50 1.0×	8	333
Evangelos Eleftherakis-Papaiakovou Greece	6	43 0.3×	231 1.7×	433 3.7×	209 3.1×	9 0.2×	10	549
Sotirios Sachanas Greece	12	158 1.2×	109 0.8×	146 1.2×	6 0.1×	43 0.9×	34	384

Countries citing papers authored by Aref Chehal

Since Specialization

Citations

This map shows the geographic impact of Aref Chehal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aref Chehal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aref Chehal more than expected).

Fields of papers citing papers by Aref Chehal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aref Chehal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aref Chehal. The network helps show where Aref Chehal may publish in the future.

Co-authorship network of co-authors of Aref Chehal

This figure shows the co-authorship network connecting the top 25 collaborators of Aref Chehal. A scholar is included among the top collaborators of Aref Chehal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aref Chehal. Aref Chehal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Otrock, Zaher K., Jawad A. Makarem, Joseph Kattan, et al.. (2009). Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study.. PubMed. 56(1). 16–21.

Shamseddine, Ali, Zaher K. Otrock, Maya Charafeddine, et al.. (2006). A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer. Oncology. 70(5). 330–338. 2 indexed citations

Shamseddine, Ali, et al.. (2006). Cisplatin and vinorelbine (PVn) for the treatment of advanced breast cancer: 10 years of experience.. PubMed. 52(3). 126–30. 1 indexed citations

Shamseddine, Ali, Aref Chehal, Yasser Abou Mourad, et al.. (2005). A Clinical Phase II Study of Cisplatinum and Vinorelbine (PVn) in Advanced Breast Carcinoma (ABC). American Journal of Clinical Oncology. 28(4). 393–398. 4 indexed citations

Fuleihan, Ghada El‐Hajj, Mariana Salamoun, Yasser Abou Mourad, et al.. (2005). Pamidronate in the Prevention of Chemotherapy-Induced Bone Loss in Premenopausal Women with Breast Cancer: A Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 90(6). 3209–3214. 78 indexed citations

Hajj, Ihab I. El, Aref Chehal, & Nagi S. El Saghir. (2005). Recurrent GI Bleeding and Surgery Following the Initial Response to Imatinib Therapy in GIST of the Stomach. Digestive Diseases and Sciences. 50(1). 65–69. 6 indexed citations

Shamseddine, Ali, Fadi H. Mourad, Aref Chehal, et al.. (2005). Comparative Pharmacokinetics and Metabolic Pathway of Gemcitabine During Intravenous and Intra-arterial Delivery in Unresectable Pancreatic Cancer Patients. Clinical Pharmacokinetics. 44(9). 957–967. 24 indexed citations

Husari, Ahmad, et al.. (2005). Metastatic thymoma to the peritoneum: A case report. 1(3). 89–92.

Shamseddine, Ali, Aref Chehal, Ihab M. Usta, et al.. (2004). Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review. Journal of Clinical Apheresis. 19(1). 5–10. 24 indexed citations

10.

El-Hajj, Ihab I., Aref Chehal, Ali Shamseddine, Yasser Abou Mourad, & Alì Taher. (2004). Hb H Disease and Multiple Myeloma. Hemoglobin. 28(1). 79–82. 2 indexed citations

11.

Chehal, Aref, Alì Taher, Mazen K. Khalil, & Ali Shamseddine. (2004). Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer. The Breast. 13(5). 421–424. 3 indexed citations

12.

Chehal, Aref, Ali Shamseddine, Yasser Abou Mourad, & Alì Taher. (2004). Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody. Annals of Hematology. 83(5). 319–321. 14 indexed citations

13.

Salem, Ziad, Pierre Zalloua, Aref Chehal, et al.. (2003). Effective treatment of hypereosinophilic syndrome with imatinib mesylate. The Hematology Journal. 4(6). 410–412. 20 indexed citations

14.

Chehal, Aref, Alì Taher, & Ali Shamseddine. (2003). IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality. Clinical & Laboratory Haematology. 25(3). 187–190. 7 indexed citations

15.

Chehal, Aref, et al.. (2003). Hypertransfusion: A Successful Method of Treatment in Thalassemia Intermedia Patients With Spinal Cord Compression Secondary to Extramedullary Hematopoiesis. Spine. 28(13). E245–E249. 52 indexed citations

16.

Chehal, Aref, Alì Taher, Muhieddine Seoud, & A. Shamseddine. (2003). Idiopathic thrombocytopenic purpura and ovarian cancer.. PubMed. 24(6). 539–40. 10 indexed citations

17.

Aoun, Elie, et al.. (2003). Transfusion‐associated GVHD: 10 years’ experience at the American University of Beirut—Medical Center. Transfusion. 43(12). 1672–1676. 31 indexed citations

18.

Chehal, Aref, et al.. (2003). . Spine. 28(13). E245–E249. 4 indexed citations

19.

Chehal, Aref, Alì Taher, & Ali Shamseddine. (2002). SICKLEMIA WITH MULTI-ORGAN FAILURE SYNDROME AND THROMBOTIC THROMBOCYTOPENIC PURPURA. Hemoglobin. 26(4). 345–351. 22 indexed citations

20.

Chehal, Aref, et al.. (2002). β-THALASSEMIA INTERMEDIA AND NON-HODGKIN'S LYMPHOMA. Hemoglobin. 26(3). 219–225. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact